OUR VISION IS TO REDUCE ILLNESS AND DEATH ASSOCIATED WITH FUNGAL DISEASES WORLDWIDE.

News

Keep up to date with the latest news items from GAFFI.

New figures show 138 million women suffer from recurrent thrush

Posted .

Around 138 million women are affected by a distressing but treatable fungal infection world-wide, according to a research review by University of Manchester scientists. And the incidence of recurrent thrush, warns lead researcher Dr Riina Rautemaa-Richardson, is set to rise to an estimated 158 million people by 2030. The team from The University of Manchester… Read more »

Read more >

Burden of fungal disease for 13 countries published in Journal of Fungi

Posted .

Gaps in basic data on disease prevalence hinders accurate burden estimates for most fungal diseases: there is a 15-fold difference between the official asthma prevalence in Kazakhstan and the likely true minimal estimate; almost no epidemiological data on fungal diseases in Jordan; no direct records of fungal keratitis from many countries; and no data on… Read more »

Read more >

Two point-of-care tests for invasive aspergillosis launched

Posted .

Prompt initiation of antifungal therapy can make the difference between life and death for patients with invasive aspergillosis. Point-of-care diagnostics (POC; a.k.a. ‘bedside testing’) allows clinicians to begin treatment right away while awaiting confirmation by culture and histological examination. Two companies have released affordable and simple to use POC tests for invasive aspergillosis. Both tests… Read more »

Read more >

WHO releases its first Essential Diagnostic List

Posted .

Following its Advisory meeting in April 2018, the World Health Organisation (WHO) has issued its first listing of Essential Diagnostics. The list is split into general laboratory tests (n= 58) and specific tests for key infections (HIV, TB, hepatitis, syphilis and human papilloma virus) (n=55). It is also split into sections relating to testing in… Read more »

Read more >

GAFFI annual report released alongside burden of fungal diseases estimates for Benin and Sweden

Posted .

GAFFI released its 2017 annual report at the European Conference of Clinical Microbiology and Infectious Diseases (ECCMID) following its Board meeting. GAFFI’s Guatemala program takes centre stage showing the immediate diagnostic benefits of rapid screening of ill patients with HIV infection for AIDS for cryptococcal diseases, histoplasmosis and tuberculosis. Other highlights from 2017 include inclusion… Read more »

Read more >